Dr Reddy’s gearing up for Canada semaglutide launch, to expand India portfolio
Dr Reddy's Laboratories is days away from launching a generic version of semaglutide in Canada, where it was the first to receive regulatory approval, and is simultaneously expanding its oral semaglutide offering in India, with plans to enter 80+ countries over the next two years. 
Original Source
Read the full article at Livemint →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.